Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Iowa Public Radio
52m
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
54m
on MSN
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Waltz resigns from House
Coast Guard chief fired
Released from prison
Can target schools, churches
Raising prices again
Silk Road founder pardoned
'Days of Our Lives' star dies
Birthright citizenship suit
SCOTUS grants new hearing
Agent fatally shot in VT
National championship win
Judge blocks report release
Elise Stefanik testifies
NC Rep. Joe John resigns
Trailblazing cartoonist dies
Former prosecutor faces trial
Milley's portrait taken down
Set to leave DOGE
Acting defense secretary
CBP One app shut down
Taliban frees 2 Americans
Fire at ski resort in Turkey
Gulf Coast winter storm
Israel’s top general resigns
Discuss strengthening ties
Antisemitism lawsuits settled
Doug Collins hearing
Djokovic beats Alcaraz
FDA approves nasal spray
To host '25 Grammy Awards
FBI acting chief retires
Related topics
Johnson & Johnson
Spravato
Food and Drug Administration
Feedback